Delivery Order SPE2DB25D3021-SPE2DB25FQXMR

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.04 firm fixed-price delivery order is for the supply of 4567059430 - VYVANSE 30 MG CAPSULE 100S, with a period of performance through January 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.78 firm fixed-price delivery order is for the supply of VYVANSE 60 MG CAPSULE 100S to support federal healthcare programs. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.63 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,708.38 firm-fixed-price delivery order is for the supply of 100 units of 30 mg VYVANSE capsules. The contract has a period of performance through December 18, 2024 and was awarded on December 17, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,110.55 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,700.16 firm-fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 firm fixed-price delivery order is for 4566895899 VYVANSE 50 MG CAPSULE 100S, with a period of performance through January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $5,231.94 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.34 delivery order contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,129.72 Firm Fixed Price delivery order contract is for the provision of 4566831562 VYVANSE 20 MG CAPSULE 100S, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
  • SPE2DB25D3021
    Indefinite Delivery Contract
  • SPE2DB25D3021-SPE2DB25FQXMR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,444.16 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through February 4, 2025.

This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/5/25, 9:52 AM